SPOTLIGHT: AMA conflict of interest policy still in the works, a year later

Some might say a year of debate is long enough, even for Congress. But at the American Medical Association, they're taking their time over a new ethics policy designed to limit pharmaceutical company and devicemaker influence on continuing medical education for doctors. Of course, it doesn't help that the AMA drew substantial CME funding from pharma, which climbed to $1.2
billion between 1998 and 2006, or about 50 percent of its CME budget. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.